Bt Toxin Receptor Engineering for Insect Resistance Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The development of insect resistance to Bacillus thuringiensis (Bt) toxins poses a significant challenge, as single glycoproteins are not essential for toxin activity, and resistance mechanisms such as reduced receptor binding and gene mutations interfere with toxin-receptor interactions, necessitating improved methods for identifying and designing insecticidal toxins and managing resistance.
Innovation Solution
The development of recombinant receptor polypeptides and DNA encoding these receptors, along with methods to assess binding affinity and cytotoxicity, allows for the identification and engineering of novel or enhanced insecticidal toxins, and the use of gene suppression to reduce receptor expression, combined with transgenic host cells and plants to control insect populations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Cry toxins are used for insect control, then insecticidal activity is achieved, but insect resistance develops over time
Solution Approach 1:
The patent segments the toxin-receptor interaction system by identifying and characterizing multiple distinct receptor types (cadherin-like proteins, ABC transporters, aminopeptidases, alkaline phosphatases) that Cry toxins can bind to. This segmentation allows for understanding that blocking one receptor pathway does not completely eliminate toxin activity, as alternative receptors remain available, thereby delaying resistance development.
Solution Approach 2:
The patent employs composite receptor systems where multiple different receptor proteins work together in the toxin binding process. By characterizing these composite systems, the invention enables design of toxins that can engage multiple receptor types simultaneously or alternatively, making it harder for insects to develop resistance through single-receptor mutations.
2Reliability
If receptor binding is reduced as a resistance mechanism, then toxin effectiveness decreases, but understanding binding mechanisms enables design of improved toxins
Solution Approach 1:
The patent utilizes feedback from characterized receptor structures and binding mechanisms to iteratively improve toxin design. By studying how insects reduce receptor binding as a resistance mechanism, the invention feeds this information back into rational toxin engineering to create variants with enhanced or alternative binding capabilities, thereby maintaining effectiveness despite resistance pressures.
Solution Approach 2:
The patent applies parameter changes by modifying toxin amino acid sequences based on detailed knowledge of receptor binding interfaces. Through site-directed mutagenesis and structure-guided design, the invention alters binding parameters such as affinity, specificity, and binding kinetics to overcome reduced receptor binding caused by insect resistance mechanisms.
3Reliability
If multiple receptors are involved in toxin action, then specificity and potency increase, but complexity of identifying and characterizing receptors increases
Solution Approach 1:
The patent segments the complex receptor identification process by systematically categorizing receptors into distinct families (cadherin-like, ABC transporters, aminopeptidases, alkaline phosphatases) based on their structural and functional characteristics. This segmentation approach breaks down the overwhelming complexity into manageable categories, enabling systematic characterization of each receptor type's contribution to toxin binding.
Solution Approach 2:
The patent employs intermediary approaches by using recombinant receptor proteins and cell-based expression systems as mediators to study toxin-receptor interactions. These intermediaries allow controlled experimentation and characterization of individual receptor-toxin pairs, simplifying the complex multi-receptor system into discrete, analyzable units while maintaining biological relevance.
Data Source
AI summary
The invention relates to identification and characterization of recombinant DNA and polypeptides for specific Bt toxin receptors. In particular, the Bt toxin receptors of the invention include those derived from the Lepidopteran super family including the species Trichoplusiani ni, Pseudoplusia includens, Helicoverpa zea, and Spodoptera frugiperda. The receptors of the invention further include those derived from the Coleopteran super family and particularly from the species Diabrotica virgifera virgifera. The recombinant DNA and polypeptides so provided are useful in the identification and design of novel Bt toxin receptor ligands including novel or improved insecticidal toxins for use in a variety of agricultural applications. Materials and methods for identifying novel toxins are also disclosed herein. The invention also provides methods for selecting toxins to combine to control insect populations by manipulating Bt toxin receptor.